ATM Phosphorylation of Mdm2 Ser394 Regulates the Amplitude and Duration of the DNA Damage Response in Mice
Open accessAbstract
DNA damage induced by ionizing radiation activates the ATM kinase, which subsequently stabilizes and activates the p53 tumor suppressor protein. Although phosphorylation of p53 by ATM was found previously to modulate p53 levels and transcriptional activities in vivo, it does not appear to be a major regulator of p53 stability. We have utilized mice bearing altered Mdm2 alleles to demonstrate that ATM phosphorylation of Mdm2 serine 394 is required for robust p53 stabilization and activation after DNA damage. In addition, we demonstrate that dephosphorylation of Mdm2 Ser394 regulates attenuation of the p53-mediated response to DNA damage. Therefore, the phosphorylation status of Mdm2 Ser394 governs p53 protein levels and functions in cells undergoing DNA damage.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mutation of Ser394 to alanine in mouse MDM2 in vivo removes an ATM phosphorylation site, engenders radioresistance and increases the rate of spontaneous tumorigenesis to that observed in Trp53-hemizygous animals.
“By contrast, the mutation of Ser394 to alanine (Ser394Ala) in mouse MDM2 in vivo removes an ATM phosphorylation site, engenders radioresistance and increases the rate of spontaneous tumorigenesis to that observed in Trp53-hemizygous animals47.”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018 · see citing works
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · see citing works
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · see citing works
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · see citing works
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · see citing works
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051 · see citing works
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 3× · see citing works
“Mdm2 / mice die at E5–E6 during development due to aberrant p53-mediated apoptosis (Jones et al., 1995; Montes de Oca Luna et al., 1995), whereas Mdm2 overexpression in mice inhibits p53 tumor suppression, resulting in the formation of lymphomas, soft tissue sarcomas, and osteosarcomas (Jones et…”
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 3× · see citing works
“Mdm2 / mice die at E5–E6 during development due to aberrant p53-mediated apoptosis (Jones et al., 1995; Montes de Oca Luna et al., 1995), whereas Mdm2 overexpression in mice inhibits p53 tumor suppression, resulting in the formation of lymphomas, soft tissue sarcomas, and osteosarcomas (Jones et al.”
Self-citationHickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220 · see citing works
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
Jeffers, J. R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J. A., Maclean, K. H., Han, J., Chittenden, T., Ihle, J. N., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00244-7 · Cited by 880 · see citing works
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 716 · see citing works
Assessing TP53 status in human tumours to evaluate clinical outcome
Soussi, T., & Béroud, C. (2001) · Nature reviews. Cancer · doi:10.1038/35106009 · Cited by 659 · see citing works
The role of p53 in determining sensitivity to radiotherapy
Gudkov, A. V., & Komarova, E. A. (2003) · Nature reviews. Cancer · doi:10.1038/nrc992 · Cited by 569 · see citing works
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542 · see citing works
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Shiloh, Y., & Shkedy, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14973 · Cited by 461 · see citing works
O’Gorman, S., Dagenais, N., Qian, M., & Marchuk, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14602 · Cited by 436 · see citing works
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
Lu, X., Nannenga, B., & Donehower, L. A. (2005) · Genes & Development · doi:10.1101/gad.1291305 · Cited by 389 · see citing works
Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation
Stommel, J. M., & Wahl, G. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600145 · Cited by 386 · see citing works
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
Jones, S. N., Hancock, A. R., Vogel, H., Donehower, L. A., & Bradley, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15608 · Cited by 386 · see citing works
Self-citationp53-deficient mice are extremely susceptible to radiation-induced tumorigenesis
Kemp, C. J., Wheldon, T. E., & Balmain, A. (1994) · Nature Genetics · doi:10.1038/ng0994-66 · Cited by 366 · see citing works
Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways
Shreeram, S., Demidov, O. N., Hee, W. K., Yamaguchi, H., Onishi, N., Kek, C., Timofeev, O. N., Dudgeon, C., Fornace, A. J., Anderson, C. W., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.07.010 · Cited by 350 · see citing works
Juven‐Gershon, T., Barak, Y., Zauberman, A., George, D. L., & Oren, M. (1993) · PubMed · Cited by 332 · see citing works
MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
Bond, G. L., Hu, W., & Levine, A. J. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053332627 · Cited by 310 · see citing works
The Wip1 Phosphatase Acts as a Gatekeeper in the p53-Mdm2 Autoregulatory Loop
Lu, X., Ma, O., Nguyen, T., Jones, S. N., Oren, M., & Donehower, L. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.033 · Cited by 282 · see citing works
Self-citationThe p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 252 · see citing works
Lu, X., Nguyen, T., Moon, S.-H., Darlington, Y. F., Sommer, M., & Donehower, L. A. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9127-x · Cited by 244 · see citing works
Komarova, E. A., Kondratov, R. V., Wang, K., Christov, K. T., Golovkina, T. V., Goldblum, J. R., & Gudkov, A. V. (2004) · Oncogene · doi:10.1038/sj.onc.1207494 · Cited by 235 · see citing works
Regulation of Transcription Functions of the p53 Tumor Suppressor by the mdm-2 Oncogene
Chen, J., Lin, J., & Levine, A. J. (1995) · Molecular Medicine · doi:10.1007/bf03401562 · Cited by 214 · see citing works
Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo
Pellegrini, M., Celeste, A., Difilippantonio, S., Guo, R., Wang, W., Feigenbaum, L., & Nussenzweig, A. (2006) · Nature · doi:10.1038/nature05112 · Cited by 204 · see citing works
Gajjar, M. K., Candeias, M. M., Malbert-Colas, L., Mazars, A., Fujita, J., Olivares‐Illana, V., & Fåhræus, R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.016 · Cited by 168 · see citing works
Phosphorylation of murine p53 at Ser-18 regulates the p53 responses to DNA damage
Chao, C., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220252297 · Cited by 166 · see citing works
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Cheng, Q., Chen, L., Li, Z., Lane, W. S., & Chen, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.294 · Cited by 165 · see citing works
Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression
Chao, C., Herr, D., Chun, J., & Xu, Y. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601167 · Cited by 158 · see citing works
Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice
Sluss, H. K., Armata, H., Gallant, J., & Jones, S. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.976-984.2004 · Cited by 152 · see citing works
Self-citationCell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses
Chao, C., Hergenhahn, M., Kaeser, M. D., Wu, Z., Saito, S., Iggo, R., Hollstein, M., Appella, E., & Xu, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306938200 · Cited by 141 · see citing works
Jack, M. T., Woo, R. A., Hirao, A., Cheung, A., Mak, T. W., & Lee, P. W. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152053599 · Cited by 139 · see citing works
Mutation of Mouse p53 Ser23 and the Response to DNA Damage
Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2441-2449.2002 · Cited by 103 · see citing works
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79 · see citing works
Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
Cheng, Q., Cross, B. L., Li, B., Chen, L., Li, Z., & Chen, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05553-11 · Cited by 73 · see citing works
Gurley, K. E., & Kemp, C. J. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0223 · Cited by 21 · see citing works
Phosphorylation of p53 Serine 18 Upregulates Apoptosis to Suppress Myc-Induced Tumorigenesis
Sluss, H. K., Gannon, H., Coles, A. H., Shen, Q., Eischen, C. M., & Jones, S. N. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0324 · Cited by 15 · see citing works
Self-citationGeneration of an Mdm2 conditional allele in mice
Steinman, H. A., & Jones, S. N. (2002) · genesis · doi:10.1002/gene.10035 · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
2 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 723 · see citing works
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 291 · see citing works
Chibaya, L., Karim, B. O., Zhang, H., & Jones, S. N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003193118 · Cited by 191 · see citing works
Self-citationThe ATM signaling network in development and disease
Stracker, T. H., Roig, I., Knobel, P. A., & Marjanović, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00037 · Cited by 173 · see citing works
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168 · see citing works
Limiting the power of p53 through the ubiquitin proteasome pathwayPreprint
Pant, V., & Lozano, G. (2014) · Genes & Development · doi:10.1101/gad.247452.114 · Cited by 165 · see citing works
Eischen, C. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026096 · Cited by 161 · see citing works
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wang, W., Albadari, N. G., Du, Y., Fowler, J. F., Sang, H. T., Xian, W., McKeon, F., Li, W., Zhou, J., & Zhang, R. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001026 · Cited by 147 · see citing works
Understanding p53 functions through p53 antibodies
Sabapathy, K., & Lane, D. P. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz010 · Cited by 139 · see citing works
Wienken, M., Dickmanns, A., Nemajerová, A., Kramer, D., Najafova, Z., Weiss, M., Karpiuk, O., Kassem, M. S., Zhang, Y., Lozano, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.008 · Cited by 109 · see citing works
Menon, V., & Povirk, L. F. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_17 · Cited by 103 · see citing works
p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Huang, Y., Che, X., Wang, P., & Qu, X. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.001 · Cited by 92 · see citing works
Pant, V., Xiong, S., Jackson, J. G., Post, S. M., Abbas, H. A., Quintás‐Cardama, A., Hamir, A. N., & Lozano, G. (2013) · Genes & Development · doi:10.1101/gad.227249.113 · Cited by 84 · see citing works
Yi, H., Yan, X., Luo, Q., Yuan, L., Li, B., Pan, W., Zhang, L., Chen, H., Wang, J., Zhang, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0765-8 · Cited by 71 · see citing works
The versatile functions of ATM kinase
Xu, B., & Boohaker, R. J. (2014) · Biomedical Journal · doi:10.4103/2319-4170.125655 · Cited by 70 · see citing works
Li, X., Si, Y., Liang, J., Li, M., Wang, Z., Qin, Y., & Sun, L. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.05.209 · Cited by 72 · see citing works
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 70 · see citing works
Self-citationMDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome
Li, Y., Stockton, M. E., Bhuiyan, I., Eisinger, B. E., Gao, Y., Miller, J. L., Bhattacharyya, A., & Zhao, X. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9370 · Cited by 66 · see citing works
Purbey, P. K., Scumpia, P. O., Kim, P. J., Tong, A.-J., Iwamoto, K. S., McBride, W. H., & Smale, S. T. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.017 · Cited by 65 · see citing works
HDMX Folds the Nascent p53 mRNA following Activation by the ATM Kinase
Malbert-Colas, L., Ponnuswamy, A., Olivares‐Illana, V., Tournillon, A.-S., Naski, N., & Fåhræus, R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.035 · Cited by 55 · see citing works
Molecular signaling cascades involved in nonmelanoma skin carcinogenesis
Feehan, R. P., & Shantz, L. M. (2016) · Biochemical Journal · doi:10.1042/bcj20160471 · Cited by 54 · see citing works
A single synonymous mutation determines the phosphorylation and stability of the nascent protein
Karakostis, K., Gnanasundram, S. V., López, I., Thermou, A., Wang, L., Nylander, K., Olivares‐Illana, V., & Fåhræus, R. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy049 · Cited by 52 · see citing works
Regulation of MDM2 Stability After DNA Damage
Li, J., & Kurokawa, M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24994 · Cited by 48 · see citing works
Lane, D. P., & Verma, C. S. (2012) · Genes & Cancer · doi:10.1177/1947601912458285 · Cited by 41 · see citing works
Sam68 Is Required for DNA Damage Responses via Regulating Poly(ADP-ribosyl)ation
Sun, X., Fu, K., Hodgson, A., Wier, E. M., Wen, M. G., Kamenyeva, O., Xia, X., Koo, L. Y., & Wan, F. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002543 · Cited by 42 · see citing works
SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle
Lu, Y.-F., Xu, X.-P., Lu, X.-P., Zhu, Q., Liu, G., Bao, Y.-T., Wen, H., Li, Y.-L., Gu, W., & Zhu, W.-G. (2020) · Oncogene · doi:10.1038/s41388-020-1305-5 · Cited by 40 · see citing works
Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
Magnussen, H., Ahmed, S. F., Sibbet, G. J., Hristova, V. A., Nomura, K., Hock, A. K., Archibald, L. J., Jamieson, A. G., Fushman, D., Vousden, K. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15783-y · Cited by 37 · see citing works
Switching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 38 · see citing works
DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction
Wang, Z. P., Inuzuka, H., Zhong, J., Fukushima, H., Wan, L., Liu, P., & Wei, W. (2012) · Oncotarget · doi:10.18632/oncotarget.640 · Cited by 36 · see citing works
Carr, M. I., Roderick, J. E., Gannon, H., Kelliher, M. A., & Jones, S. N. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.014 · Cited by 34 · see citing works
Self-citationSMG7 is a critical regulator of p53 stability and function in DNA damage stress response
Luo, H., Cowen, L. E., Yu, G., Jiang, W. G., & Tang, Y. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.42 · Cited by 33 · see citing works
p53mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
Karakostis, K., Ponnuswamy, A., Fusée, L. T. S., Bailly, X., Laguerre, L., Worrall, E. G., Vojtesek, B., Nylander, K., & Fåhræus, R. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw012 · Cited by 33 · see citing works
UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
Du, C., Wu, H., & Leng, R. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6555 · Cited by 32 · see citing works
Targeting ATM pathway for therapeutic intervention in cancer
Khalil, H. S., Tummala, H., Chakarov, S., Zhelev, N., & Lane, D. P. (2012) · Biodiscovery · doi:10.7750/biodiscovery.2012.1.3 · Cited by 28 · see citing works
It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53
Love, I. M., & Grossman, S. R. (2012) · Genes & Cancer · doi:10.1177/1947601912455198 · Cited by 28 · see citing works
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 26 · see citing works
Medina‐Medina, I., García-Beltrán, P., la Mora, I. D. L. M.-D., Oria‐Hernández, J., Millot, G., Fåhræus, R., Reyes‐Vivas, H., Sampedro, J. G., & Olivares‐Illana, V. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00113-16 · Cited by 27 · see citing works
Alik, A., Bouguechtouli, C., Julien, M., Bermel, W., Ghouil, R., Zinn‐Justin, S., & Theillet, F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202002288 · Cited by 25 · see citing works
ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways
Fedak, E. A., Adler, F. R., Abegglen, L. M., & Schiffman, J. D. (2021) · Bulletin of Mathematical Biology · doi:10.1007/s11538-021-00868-6 · Cited by 26 · see citing works
Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis
Gannon, H., & Jones, S. N. (2012) · Genes & Cancer · doi:10.1177/1947601912455324 · Cited by 25 · see citing works
Self-citationDicer Cooperates with p53 to Suppress DNA Damage and Skin Carcinogenesis in Mice
Lyle, S. R., Hoover, K. L., Colpan, C., Zhu, Z., Matijašević, Z., & Jones, S. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100920 · Cited by 21 · see citing works
Self-citationShaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures
Karakostis, K., & Fåhræus, R. (2019) · BMC Cancer · doi:10.1186/s12885-019-6118-y · Cited by 20 · see citing works
Mouse modelling of the MDM2/MDMX−p53 signalling axis
Tackmann, N. R., & Zhang, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx006 · Cited by 21 · see citing works
MDM2 Overexpression, Activation of Signaling Networks, and Cell Proliferation
Deb, S. P., Singh, S., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_12 · Cited by 17 · see citing works
Fu, K., Sun, X., Wier, E. M., Hodgson, A., Hobbs, R. P., & Wan, F. (2016) · eLife · doi:10.7554/elife.21957 · Cited by 17 · see citing works
PIAS3 promotes homology-directed repair and distal non-homologous end joining
LIU, S., Fan, Z., Geng, Z., Zhang, H., Ye, Q., Jiao, S., & Xu, X. (2013) · Oncology Letters · doi:10.3892/ol.2013.1472 · Cited by 16 · see citing works
What do we need to know and understand about p53 to improve its clinical value?
Salomao, N., Karakostis, K., Hupp, T., Vollrath, F., Vojtesek, B., & Fahraeus, R. (2021) · The Journal of Pathology · doi:10.1002/path.5677 · Cited by 15 · see citing works
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment
Rozpędek‐Kamińska, W., Pytel, D., Nowak-Zduńczyk, A., Lewko, D., Wojtczak, R., Diehl, J. A., & Majsterek, I. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180117102233 · Cited by 15 · see citing works
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo
Comiskey, D. F., Jacob, A. G., Sanford, B. L., Montes, M., Goodwin, A., Steiner, H. E., Matsa, E., Tapia-Santos, A. S., Bebee, T. W., Grieves, J. L., et al. (2017) · Oncogene · doi:10.1038/onc.2017.282 · Cited by 13 · see citing works
Che, J., Lu, Y., Sun, K., Feng, C., Dong, A., & Jiao, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2536 · Cited by 12 · see citing works
Low power lasers on genomic stability
Trajano, L. A. D. S. N., Sergio, L. P. D. S., Stumbo, A. C., Mencalha, A. L., & da Fonseca, A. D. S. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.02.010 · Cited by 11 · see citing works
Carr, M. I., Roderick, J. E., Zhang, H., Woda, B. A., Kelliher, M. A., & Jones, S. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611798114 · Cited by 11 · see citing works
Self-citationKwak, J., Choi, J., & Jang, K. L. (2017) · Oncotarget · doi:10.18632/oncotarget.20337 · Cited by 11 · see citing works
Considering the Role of Murine Double Minute 2 in the Cardiovascular System?
Lam, B., & Roudier, E. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00320 · Cited by 11 · see citing works
Mujoo, K., Hunt, C. R., PANDITA, R. K., Mauro Ferrari, B., Krishnan, S., Cooke, J. P., Hahn, S. M., & Pandita, T. K. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0743 · Cited by 10 · see citing works
E3 Ubiquitin Ligases in Cancer and Their Pharmacological Targeting
Ong, J. Y., & Torres, J. Z. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82883 · Cited by 8 · see citing works
Fan, Y., Fan, H., Quan, Z., & Wu, X. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1899200 · Cited by 9 · see citing works
Post-translational regulation enables robust p53 regulation
Shin, Y.-J., Chen, K., Sayed, A. H., Hencey, B., & Shen, X. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-83 · Cited by 9 · see citing works
Weak Magnetic Fields Enhance the Efficacy of Radiation Therapy
Iwamoto, K. S., Sandstrom, R. E., Bryan, M., Liu, Y., Elgart, S. R., Sheng, K., Steinberg, M. L., McBride, W. H., & Low, D. A. (2021) · Advances in Radiation Oncology · doi:10.1016/j.adro.2021.100645 · Cited by 8 · see citing works
Li, Y., Feng, N.-N., Zhang, G.-H., Wang, Q., Hao, Y.-H., Ya-Nanzhang, Long, C., Li, Y., Brandt‐Rauf, P. W., & Xia, Z.-L. (2013) · International Journal of Occupational Medicine and Environmental Health · doi:10.2478/s13382-013-0155-6 · Cited by 8 · see citing works
Alik, A., Bouguechtouli, C., Julien, M., Bermel, W., Ghouil, R., Zinn‐Justin, S., & Theillet, F. (2020) · Angewandte Chemie · doi:10.1002/ange.202002288 · Cited by 8 · see citing works
What a Difference a Phosphate Makes: Life or Death Decided by a Single Amino Acid in MDM2
Li, Y., & Wahl, G. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.033 · Cited by 6 · see citing works
Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function
Uhrík, L., Wang, L., Hároníková, L., Medina‐Medina, I., Rebolloso‐Gómez, Y., Chen, S., Vojtěšek, B., Fåhræus, R., Hernychová, L., & Olivares‐Illana, V. (2019) · Biochemical Journal · doi:10.1042/bcj20190687 · Cited by 6 · see citing works
Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms
Karakostis, K., López, I., Peña-Balderas, A. M., Fåhareus, R., & Olivares‐Illana, V. (2020) · Biomolecules · doi:10.3390/biom11010036 · Cited by 6 · see citing works
Intra molecular interactions in the regulation of p53 pathway
Chen, J. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.09.23 · Cited by 5 · see citing works
The DNA Damage Response Mediates Apoptosis and Tumor Suppression
Baran, K., Rodríguez, D. A., & Green, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_7 · Cited by 6 · see citing works
p53 regulation by ubiquitin and ubiquitin-like modifications
Wang, Y., Zhang, C., Wang, J., & Liu, J. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00067-0 · Cited by 5 · see citing works
Likhatcheva, M., Gieling, R. G., Brown, J. A. L., Demonacos, C., & Williams, K. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720194 · Cited by 4 · see citing works
HDM2 and HDMX Proteins in Human Cancer
Hároníková, L., & Vojtěšek, B. (2018) · Klinicka onkologie · doi:10.14735/amko20182s63 · Cited by 4 · see citing works
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum
Bernardo, S., Brunet, L. J., Thomas, Q. D., Bracquemond, D., Bouclier, C., Colomb, M., Mancini, M., Fabbrizio, E., Santos, A., Rasamizafy, S. F., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00354-9 · Cited by 3 · see citing works
Moraleva, A. A., Антипова, Н. В., Pavlov, P., Dobrochaeva, K. L., & Rubtsov, Y. P. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1749992 · Cited by 3 · see citing works
Redox signaling in development: An emerging frontier.
Ulfig, A., & Jakob, U. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.07.005 · Cited by 1 · see citing works
Yi, H., Han, Y., Wang, X., Li, Q., Xiong, L., & Li, S. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02049-y · Cited by 3 · see citing works
Koyama, M., Yamaguchi, K. D., Chigusa, Y., Yamanoi, K., Taki, M., Sunada, M., Horie, A., Hamanishi, J., Minamiguchi, S., & Mandai, M. (2023) · International Cancer Conference Journal · doi:10.1007/s13691-022-00591-6 · Cited by 2 · see citing works
hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex
Huang, X., Zhao, Y. T., Wei, M., Zhuge, R., & Zheng, X. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad015 · Cited by 2 · see citing works
The Role of the DNA Damage Response in Ataxia-Telangiectasia Syndrome
Ribes‐Zamora, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84902 · Cited by 1 · see citing works
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers
Eu, J. Q., Salleh, N. A. B. M., Hirpara, J. L., Ohi, N., Omori, E., Tan, T. Z., Seet, J. E., Hue, S. S., Chan, S. J., Lim, D. X. Y., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-025-01257-1 · Cited by 1 · see citing works
Puszyński, K., Jonak, K., Kurpas, M. K., Janus, P., & Szołtysek, K. (2014) · IWBBIO · Cited by 1 · see citing works
Dynamics of the p53 response to ionizing and ultraviolet radiationPreprint
Fedak, E. A., Adler, F. R., Young, E. L., Abegglen, L. M., & Schiffman, J. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/367995 · Cited by 1 · see citing works
Touqan, N. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Husaini, R. (2014) · Bradford Scholars (University of Bradford)
Vila, A. (2018) · DalSpace (Dalhousie University)
In Vivo Discoveries in MDM2-Mediated p53 Regulation
Tackmann, N. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z7ta-7m83
Characterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage
Haider, N. (2018) · TSpace (University of Toronto)
Effect of stress during neutron irradiation on the microstructure of type 316 stainless steel
Brager, H. R., Garner, F. A., & Guthrie, G. L. (1976) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
3’UTR-dependent dynamic changes in TP53 mRNA localization regulate p53 tumor suppressor activityPreprint
Hu, L., Misra, S., Karim, B. O., Kuhn, S. A., Salotti, J., Basu, S., Martín, N. C. R., Saylor, K. L., & Johnson, P. F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.04.487038
Bang, S., Bhatt, H. C., Chen, Y. Y., & Kurokawa, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101574
Bang, S., Bhatt, H. C., Chen, Y. Y., & Kurokawa, M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101574-1
Non-canonical functions of the MDM2 oncoprotein
Manzini, V. (2022) · doi:10.53846/goediss-9537
Germ cell tumor treatment resistance and liquid biopsy-based microRNA biomarkers
Timmerman, D. M. (2024) · doi:10.33540/2055
Bernardo, S., Thomas, Q. D., Mancini, M., Santos, A., Rasamizafy, S. F., Maacha, A.-M., Giry, A., Bousquet, E., Papon, L., Goussard, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591624
Lin, H., Ma, J., Heng, Y., Zhu, X., Jin, Q.-Y., Ding, X., Tao, L., & Lu, L. (2025) · International Journal of Cancer · doi:10.1002/ijc.35329
- Authors
- Gannon, H. S., Woda, B. A., & Jones, S. N.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Jones, Stephen N.
- ORCID
- Gannon, Hugh S.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 21
- Issue
- 5
- Pages
- 668-679
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3360886
- OpenAlex
- W2117932700
- Cited by
- 105
- References
- 48
- Citations by year
- 2026: 7 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 9 · 2020: 7 · 2019: 9 · 2018: 10 · 2017: 5 · 2016: 13 · 2015: 4 · 2014: 11 · 2013: 10 · 2012: 6
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 442 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (CA077735)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- ATM kinase, MDM2, p53 stabilization, DNA damage response, ionizing radiation, p53 activation
- MeSH terms
- Animals, DNA Damage, DNA-Binding Proteins, Enzyme Activation, Intestine, Small, Mice, Inbred C57BL, Phosphorylation, Radiation Tolerance, Serine, Spleen, Thymus Gland, Time Factors, Tumor Suppressor Protein p53, Apoptosis, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Mutation, Missense, Tumor Suppressor Proteins, Mice, Proto-Oncogene Proteins c-mdm2, Protein Stability, Mice, 129 Strain, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review